New heart attack drug trialled in Birmingham
A new partnership between BHP clinical-academic institutions and Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug, for the first time.
T…
The BHP Starter Fellowship – a catch-up with Karl
Dr Karl Payne is currently an NIHR funded Academic Clinical Lecturer in Oral & Maxillofacial Surgery and a Surgical Trainee in the West Midlands. He undertook a Birmingham Health Partners Start…
Researchers make mini ‘bone-marrow-in-a-dish’ to test cancer treatments
Scientists from BHP and Oxford University have made the first bone marrow ‘organoids’ that capture the key features of human bone marrow. The technology, for which University of Birmingham Enterpri…
Two BHP members deepen collaboration to improve health provision
Aston University and Birmingham Women’s and Children’s NHS Foundation Trust (BWC) – both members of BHP – have deepened their strategic relationship by signing a Memorandum of Understanding to co-d…
Birmingham partnership creates next generation of childhood cancer researchers
A groundbreaking local partnership has been announced in the UK’s fight against childhood cancer. Two BHP founder-members – Birmingham Children’s Hospital Charity and the University of Birmingham -…
“Born well, live well, die well” – BHP publishes report of activity 2020-2022
Following the expansion of its membership with three new partners, BHP has published its first report of activity covering September 2020 to August 2022.
Download the Birmingham Health Partners …